Presentations/Presenters
Treatment Resistance and Outcomes in Breast Cancer: Newly Identified Regulatory Pathways
Presenter: Ambika Ashraf, MD (Children's Hospital/University of Alabama at Birmingham)
Relationship: Commercial Interest(s)
Grant Recipient: Aegerion Pharmaceuticals
Grant Recipient: Ultragenyx
Treatment Resistance and Outcomes in Breast Cancer: Newly Identified Regulatory Pathways
Presenter: Camille Powe, MD (Massachusetts General Hospital)
No relevant financial relationships
Treatment Resistance and Outcomes in Breast Cancer: Newly Identified Regulatory Pathways
Presenter: Christy Hagan, PhD (University of Kansas Medical Center)
No relevant financial relationships
Treatment Resistance and Outcomes in Breast Cancer: Newly Identified Regulatory Pathways
Presenter: Rebecca Riggins, PhD (Georgetown University)
No relevant financial relationships
Androgen-Regulated Secreted Factors Promote Tumorigenesis and Immune Suppression in Breast Cancer
Presenter: Dr. Lyndsey Crump, PhD (University of Colorado Anschutz Medical Campus)
No relevant financial relationships
Androgen-Regulated Secreted Factors Promote Tumorigenesis and Immune Suppression in Breast Cancer
Presenter: Nicole Spoelstra, BS (University of Colorado Anschutz Medical Campus)
No relevant financial relationships
Androgen-Regulated Secreted Factors Promote Tumorigenesis and Immune Suppression in Breast Cancer
Presenter: Michelle Williams, PhD (University of Colorado Anschutz Medical Campus)
No relevant financial relationships
Androgen-Regulated Secreted Factors Promote Tumorigenesis and Immune Suppression in Breast Cancer
Presenter: Jennifer Richer, PhD (University of Colorado Anschutz Medical Campus)
No relevant financial relationships
Cloning, Sequencing, and Characterization of Aromatase Interacting Partner in Breast (AIPB). A New Protein Regulating Estradiol Synthesis.
Presenter: Mr. Neal M. Hall, B.S. (Mercer University School of Medicine)
No relevant financial relationships
Cloning, Sequencing, and Characterization of Aromatase Interacting Partner in Breast (AIPB). A New Protein Regulating Estradiol Synthesis.
Presenter: Neal M Hall, BS (Mercer University School of Medicine)
No relevant financial relationships
Cloning, Sequencing, and Characterization of Aromatase Interacting Partner in Breast (AIPB). A New Protein Regulating Estradiol Synthesis.
Presenter: Randy Whittal, PhD (University of Alberta)
No relevant financial relationships
Cloning, Sequencing, and Characterization of Aromatase Interacting Partner in Breast (AIPB). A New Protein Regulating Estradiol Synthesis.
Presenter: William Burak, MD (Mercer University School of Medicine)
No relevant financial relationships
Cloning, Sequencing, and Characterization of Aromatase Interacting Partner in Breast (AIPB). A New Protein Regulating Estradiol Synthesis.
Presenter: Himangshu Bose, PhD (Mercer University School of Medicine)
No relevant financial relationships
Role of ABCA1 in Myeloid Cell Function and Breast Cancer Progression
Presenter: Ms. Shruti Bendre, MS (University of Illinois)
No relevant financial relationships
Role of ABCA1 in Myeloid Cell Function and Breast Cancer Progression
Presenter: Natalia Krawczynska, PhD (University of Illinois)
No relevant financial relationships
Role of ABCA1 in Myeloid Cell Function and Breast Cancer Progression
Presenter: Indira Singaram, PhD (University of Illinois, Chicago)
No relevant financial relationships
Role of ABCA1 in Myeloid Cell Function and Breast Cancer Progression
Presenter: Wonhwa Cho, PhD (University of Illinois, Chicago)
No relevant financial relationships
Role of ABCA1 in Myeloid Cell Function and Breast Cancer Progression
Presenter: Erik R Nelson, PhD (University of Illinois at Urbana Champaign)
No relevant financial relationships
Targeting Succinate Metabolism in Endocrine Therapy Resistant, ER Positive, Breast Cancer Cells
Presenter: Dr. Surojeet Sengupta, PhD (The Hormel Institute, University of Minnesota)
No relevant financial relationships
Targeting Succinate Metabolism in Endocrine Therapy Resistant, ER Positive, Breast Cancer Cells
Presenter: Karla Andrade de Oliveira, PhD (The Hormel Institute, University of Minnesota)
No relevant financial relationships
Targeting Succinate Metabolism in Endocrine Therapy Resistant, ER Positive, Breast Cancer Cells
Presenter: Robert Clarke, Ph.D., D.Sc., F.R.S.Biol., F.R.S.Chem., F.R.S.Med. (The Hormel Institute, University of Minnesota)
No relevant financial relationships
Targeting Succinate Metabolism in Endocrine Therapy Resistant, ER Positive, Breast Cancer Cells
Presenter: Lu Jin, MS (The Hormel Institute, University of Minnesota)
No relevant financial relationships
Direct and VGLL1-Mediated Gene Regulation by GRHL2 During Mesenchymal to Epithelial Transition in Breast Cancer
Presenter: Dr. Salwa Haidar, PhD (Université de Montréal)
No relevant financial relationships
Direct and VGLL1-Mediated Gene Regulation by GRHL2 During Mesenchymal to Epithelial Transition in Breast Cancer
Presenter: Eric Audemard, MSc (Université de Montréal)
No relevant financial relationships
Direct and VGLL1-Mediated Gene Regulation by GRHL2 During Mesenchymal to Epithelial Transition in Breast Cancer
Presenter: Jonathan Boucher, PhD (Univesité de Montréal)
No relevant financial relationships
Direct and VGLL1-Mediated Gene Regulation by GRHL2 During Mesenchymal to Epithelial Transition in Breast Cancer
Presenter: Sebastien Lemieux, PhD (Université de Montréal)
No relevant financial relationships
Direct and VGLL1-Mediated Gene Regulation by GRHL2 During Mesenchymal to Epithelial Transition in Breast Cancer
Presenter: Philippe Roux, PhD (Université de Montréal)
No relevant financial relationships
Direct and VGLL1-Mediated Gene Regulation by GRHL2 During Mesenchymal to Epithelial Transition in Breast Cancer
Presenter: Sylvie Mader, PhD (Université de Montréal)
No relevant financial relationships